GSK (LON:GSK) Reaches New 1-Year High at $1,767.50

GSK plc (LON:GSK) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 1,767.50 ($22.20) and last traded at GBX 1,762.54 ($22.14), with a volume of 15331153 shares changing hands. The stock had previously closed at GBX 1,733.50 ($21.78).

Analyst Upgrades and Downgrades

Several research analysts recently commented on GSK shares. Barclays reiterated an “equal weight” rating and issued a GBX 1,725 ($21.67) price target on shares of GSK in a research report on Tuesday. Shore Capital reiterated a “buy” rating on shares of GSK in a report on Wednesday, May 1st. Berenberg Bank increased their price target on GSK from GBX 1,650 ($20.73) to GBX 1,820 ($22.86) and gave the company a “buy” rating in a report on Wednesday, February 14th. JPMorgan Chase & Co. lifted their price objective on shares of GSK from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) and gave the stock an “underweight” rating in a research note on Thursday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,950 ($24.50) target price on shares of GSK in a research note on Wednesday, April 17th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of GBX 1,675.63 ($21.05).

GSK Trading Up 0.4 %

The stock has a fifty day moving average of GBX 1,668.36 and a 200-day moving average of GBX 1,564.35. The company has a market cap of £73.15 billion, a PE ratio of 1,493.75, a PEG ratio of 1.12 and a beta of 0.27. The company has a debt-to-equity ratio of 140.82, a quick ratio of 0.73 and a current ratio of 0.88.

GSK Cuts Dividend

The business also recently declared a dividend, which will be paid on Thursday, July 11th. Investors of record on Thursday, May 16th will be paid a GBX 15 ($0.19) dividend. This represents a yield of 0.9%. The ex-dividend date is Thursday, May 16th. GSK’s dividend payout ratio is presently 5,333.33%.

Insider Activity

In other news, insider Urs Rohner acquired 434 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was purchased at an average cost of GBX 1,662 ($20.88) per share, for a total transaction of £7,213.08 ($9,061.66). In related news, insider Urs Rohner bought 434 shares of the company’s stock in a transaction on Wednesday, March 20th. The shares were acquired at an average price of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,061.66). Also, insider Emma Walmsley sold 139,792 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of GBX 1,658 ($20.83), for a total value of £2,317,751.36 ($2,911,747.94). Insiders own 1.77% of the company’s stock.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.